Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01026571 · ClinicalTrials.gov registry record

Identification of Genetic Causes of Bicuspid Aortic Valve Disease

A clinical trial of Bicuspid Aortic Valve, sponsored by Boston University.

Active
Registry status
4,000
Enrollment target
1
Study location

NCT01026571: Active study of Bicuspid Aortic Valve, sponsored by Boston University.

NCT01026571 is a study of Bicuspid Aortic Valve that is active but no longer recruiting, run by Boston University. The registered enrollment target is 4,000 participants, above the 1,850-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01026571, a study of Bicuspid Aortic Valve, is active but no longer recruiting, sponsored by Boston University.

ACTIVE NOT RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.

Conditions Studied

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2009-12
Est. Completion 2030-12
Boston University

185 total trials

What the registry record for NCT01026571 still lists

NCT01026571 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,850-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (116% higher).

The record links to 1 condition, with Bicuspid Aortic Valve appearing as the primary indexed condition, and to 0 interventions.

NCT01026571 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01026571 about?

NCT01026571 is a clinical study titled "Identification of Genetic Causes of Bicuspid Aortic Valve Disease". BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.

What is the current status of trial NCT01026571?

This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2009-12. Estimated completion is 2030-12.

What conditions does trial NCT01026571 study?

This clinical trial studies the following conditions: Bicuspid Aortic Valve.

Who is sponsoring clinical trial NCT01026571?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01026571 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bicuspid Aortic Valve

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00227253 · 4,000 participants

    Chromosome 18 Clinical Research Center

  • NCT00811148 · 4,000 participants

    Florida Center for Brain Tumor Research

  • NCT00897117 · 4,000 participants

    Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

  • NCT00899301 · 4,000 participants

    Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01026571, the US trial registry maintained by the National Library of Medicine. NCT01026571 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.